These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 2666251)

  • 21. Estimation of screening test (Hemoccult) sensitivity in colorectal cancer mass screening.
    Jouve JL; Remontet L; Dancourt V; Lejeune C; Benhamiche AM; Faivre J; Esteve J
    Br J Cancer; 2001 Jun; 84(11):1477-81. PubMed ID: 11384097
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Screening for colorectal cancer by immunochemical fecal occult blood testing.
    Saito H
    Jpn J Cancer Res; 1996 Oct; 87(10):1011-24. PubMed ID: 8957057
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Faecal occult blood testing for colorectal cancer: luxury or necessity?
    Agrez M; Evans D; Duggan J
    Aust N Z J Surg; 1990 Jun; 60(6):451-4. PubMed ID: 2346441
    [No Abstract]   [Full Text] [Related]  

  • 24. A randomised study of screening for colorectal cancer using faecal occult blood testing: results after 13 years and seven biennial screening rounds.
    Jørgensen OD; Kronborg O; Fenger C
    Gut; 2002 Jan; 50(1):29-32. PubMed ID: 11772963
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Interval cancers in a guaiac-based colorectal cancer screening programme: Consequences on sensitivity.
    Blom J; Törnberg S
    J Med Screen; 2017 Sep; 24(3):146-152. PubMed ID: 28142309
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Informative value of Hemoccult test according to the number of positive slides in mass screening of colorectal cancer].
    Tazi MA; Faivre J; Lejeune C; Dassonville F; Benhamiche AM
    Bull Cancer; 1998 Dec; 85(12):1055-9. PubMed ID: 9917557
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Validity of immunological faecal occult blood screening for colorectal cancer: a follow up study.
    Nakama H; Kamijo N; Abdul Fattah AS; Zhang B
    J Med Screen; 1996; 3(2):63-5. PubMed ID: 8849761
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [[Evaluation of various methods of studying fecal occult blood].
    Vandenbroucke A; Bourdon C; Ilunga J
    Acta Gastroenterol Belg; 1988; 51(4-5):383-90. PubMed ID: 2979053
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Reducing mortality from colorectal cancer by screening for fecal occult blood. Minnesota Colon Cancer Control Study.
    Mandel JS; Bond JH; Church TR; Snover DC; Bradley GM; Schuman LM; Ederer F
    N Engl J Med; 1993 May; 328(19):1365-71. PubMed ID: 8474513
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fecal DNA versus fecal occult blood for colorectal-cancer screening in an average-risk population.
    Imperiale TF; Ransohoff DF; Itzkowitz SH; Turnbull BA; Ross ME;
    N Engl J Med; 2004 Dec; 351(26):2704-14. PubMed ID: 15616205
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A case-control study evaluating occult blood screening for colorectal cancer with hemoccult test and an immunochemical hemagglutination test.
    Saito H; Soma Y; Nakajima M; Koeda J; Kawaguchi H; Kakizaki R; Chiba R; Aisawa T; Munakata A
    Oncol Rep; 2000; 7(4):815-9. PubMed ID: 10854550
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Mass screening for colorectal cancer].
    Faivre J; Tazi MA; Launoy G
    Rev Epidemiol Sante Publique; 1996; 44 Suppl 1():S7-14. PubMed ID: 8935859
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Population colorectal cancer screening with fecal occult blood test.
    Rennert G; Rennert HS; Miron E; Peterburg Y
    Cancer Epidemiol Biomarkers Prev; 2001 Nov; 10(11):1165-8. PubMed ID: 11700264
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Colorectal cancer screening: clinical guidelines and rationale.
    St John DJ; Macrae FA; Young GP
    Gastroenterology; 1997 Oct; 113(4):1422; author reply 1424. PubMed ID: 9322542
    [No Abstract]   [Full Text] [Related]  

  • 35. Is it reasonable to use faecal occult blood test for colorectal cancer screening?
    Musil D; Tillich J
    Acta Univ Palacki Olomuc Fac Med; 1999; 142():119-21. PubMed ID: 10743740
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of new occult blood tests for detection of colorectal neoplasia.
    St John DJ; Young GP; Alexeyeff MA; Deacon MC; Cuthbertson AM; Macrae FA; Penfold JC
    Gastroenterology; 1993 Jun; 104(6):1661-8. PubMed ID: 8500724
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Limitations of the faecal occult blood test in screening for colorectal cancer.
    Delcò F; Sonnenberg A
    Ital J Gastroenterol Hepatol; 1999 Mar; 31(2):119-26. PubMed ID: 10363196
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A case-control study to evaluate efficacy of screening for faecal occult blood.
    Lazovich D; Weiss NS; Stevens NG; White E; McKnight B; Wagner EH
    J Med Screen; 1995; 2(2):84-9. PubMed ID: 7497161
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A comparison of fecal occult-blood tests for colorectal-cancer screening.
    Allison JE; Tekawa IS; Ransom LJ; Adrain AL
    N Engl J Med; 1996 Jan; 334(3):155-9. PubMed ID: 8531970
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.